Видео ютуба по тегу Cardiac Toxicity

Vanna Dest on Cardiac Toxicity Following Radiation Therapy
Vanna Dest on Cardiac Toxicity Following Radiation Therapy
Cardiac toxicity in patients with breast cancer
Cardiac toxicity in patients with breast cancer
Cardiac Toxicity—What Causes It?
Cardiac Toxicity—What Causes It?
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Cardiac Toxicity from Cancer Treatments
Cardiac Toxicity from Cancer Treatments
Dr. Muss Discusses Evaluating Cardiac Toxicity in Patients With Breast Cancer
Dr. Muss Discusses Evaluating Cardiac Toxicity in Patients With Breast Cancer
Cardiac toxicity of immune-checkpoint inhibitors – ID 185202
Cardiac toxicity of immune-checkpoint inhibitors – ID 185202
Cardiac toxicity guidelines in older adults with hematological malignancies
Cardiac toxicity guidelines in older adults with hematological malignancies
Cardiovascular Toxicity and Immune Checkpoint Inhibitors
Cardiovascular Toxicity and Immune Checkpoint Inhibitors
Heart Minute | Detecting Cardiotoxicity During ChemoRx
Heart Minute | Detecting Cardiotoxicity During ChemoRx
Dr. Cone on Research Investigating Cardiac Toxicity of GnRH Agonists/Antagonists in Prostate Cancer
Dr. Cone on Research Investigating Cardiac Toxicity of GnRH Agonists/Antagonists in Prostate Cancer
Dr. Cone on Cardiac Toxicity With GnRH Agonists in Prostate Cancer
Dr. Cone on Cardiac Toxicity With GnRH Agonists in Prostate Cancer
Developing Strategies to Protect against Cardiovascular Toxicity of Oncology Drugs┃ Anna Hnatiuk
Developing Strategies to Protect against Cardiovascular Toxicity of Oncology Drugs┃ Anna Hnatiuk
Cardiotoxicity
Cardiotoxicity
Allan Jaffe - Monitoring for Chemotherapy Toxicity and Cardiac Troponin
Allan Jaffe - Monitoring for Chemotherapy Toxicity and Cardiac Troponin
Dr. Sage Wiener: Cardiac Toxicity Part 1
Dr. Sage Wiener: Cardiac Toxicity Part 1
Cardiac CV Toxicity of BRAF and MEK Inhibitors | JACC: CardioOncology Author Discussion
Cardiac CV Toxicity of BRAF and MEK Inhibitors | JACC: CardioOncology Author Discussion